TODAY’S NEWS Takeda to move forward with new alogliptin study - Takeda Pharmaceutical Co says it is all set to start an additional clinical trial demanded by US regulators on alogliptin, its …
Today’s Pharma News 081709
Novartis gets FDA approval for MS drug Extavia. Extavia is essentially re-branded Betaseron, and marks the entry of a new (and large player) into the MS market. It's Novartis' MS pipeline that's …
Today’s Top Three in Pharma 040209
Solvay shopping its drug business. Belgian conglomerate Solvay is eying an exit of the drug business with a sale of its pharmaceutical division that could be worth upwards of €5 billion, or $6.6 …
Today’s Top Three in Pharma 032309
Who doesn't like a like takeover speculation? In this Seeking Alpha article, Cephalon and Genzyme are discusses as potentially attractive targets. ZS Associates projects a 25% cut in #of sales reps, …
Pharma News this week
General news: Approvals: Genzyme's stem cell transplant drug Mozobil; Abbott's triglyceride drug TriLipix; Eisai's Lusedra for anesthesia. Novartis' experimental MS drug (oral) looking really good …
Pharma News this week
Glaxo: more big cuts, and the U.S. HQ needle pointing south - GlaxoSmithKline (GSK) announced that it will reduce its sales personnel by 12% to 7,500 down from 8,500. The company will slash 1,800 jobs …